Results 101 to 110 of about 43,416 (273)

Expression of microRNA related to bone remodeling regulation in plasma in patients with acromegaly

open access: yesОжирение и метаболизм, 2017
Backgraund. MiсroRNA are small regulatory factors that regulate gene expression by post-transcriptional regulation of mRNA, playing an important role in numerous cellular processes including organogenesis, apoptosis, cell proliferation and ...
Tatiana A. Grebennikova   +6 more
doaj   +1 more source

Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency [PDF]

open access: yes, 2017
Objective Epidemiological studies suggest that adult-onset growth hormone deficiency (AGHD) might increase the risk of death from cardiovascular causes. Methods This was a 6-month double-blind, placebo-controlled, randomised, cross-over trial followed by
Atkin, S. L.   +11 more
core   +1 more source

Leptin Level in Newly Diagnosed Iraqi Acromegaly Patients

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences, 2018
Acromegaly is a serious endocrine disease resulting from an increase of growth hormone in the blood. Excessive growth hormone secretion may be caused by an adenoma of the pituitary.
Noor Thair Tahir
doaj   +1 more source

SAT-267 Pregnancy in Acromegaly: Report of Five Cases [PDF]

open access: gold, 2020
Iulia Florentina Burcea   +5 more
openalex   +1 more source

The decrease in growth hormone (GH) response after repeated stimulation with GH-Releasing hormone is partly caused by an elevation of somatostatin tonus. [PDF]

open access: yes, 1996
Repeated injection of GHRH leads to a decrease in the GH response in normal subjects. Arginine (Arg) stimulates GH secretion by suppression of hypothalamic somatostatin.
Mehltretter, Gerhard   +5 more
core   +1 more source

Sclerostin levels in patients with acromegaly

open access: yesEndokrynologia Polska
Acromegaly is a rare, endocrine condition characterized by autonomous excessive secretion of growth hormone, causing numerous complications, including impairment of bone microarchitecture.
Arnika Wydra   +4 more
doaj   +1 more source

Obstructive Sleep Apnea Syndrome in Acromegaly Before and After Treatment

open access: yesTürk Uyku Tıbbı Dergisi, 2014
Introduction Obstructive sleep apnea syndrome (OSAS) prevalence in acromegaly patients is very common compared with general population. It is thought that OSAS in acromegaly patients evolve because of reversible and irreversible anatomical changes ...
Selda Korkmaz   +5 more
doaj   +1 more source

Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults [PDF]

open access: yes, 2016
Purpose: The effects of growth hormone (GH) replacement therapy on fracture risk in adult GH deficient (GHD) patients with different etiologies of pituitary GHD are not well known, due to limited data.
Bunderen, C.C. (Christa) van   +5 more
core   +5 more sources

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. [PDF]

open access: yes, 2019
Background: Pituitary adenomas have a high disease burden due to tumor growth/ invasion and disordered hormonal secretion. Germline mutations in genes such as MEN1 and AIP are associated with early onset of aggressive pituitary adenomas that can be ...
Cano González, David A.   +2 more
core  

Uso de lanreotida en combinación con cabergolina o pegvisomant en la práctica clínica en pacientes con acromegalia: el estudio ACROCOMB [PDF]

open access: yes, 2016
[Abstract] PURPOSE: To describe real-world use of lanreotide combination therapy for acromegaly. PATIENTS AND METHODS: ACROCOMB is a retrospective observational Spanish study of patients with active acromegaly treated with lanreotide combination therapy
Bernabéu, Ignacio   +18 more
core   +2 more sources

Home - About - Disclaimer - Privacy